3.55k followers • 30 symbols Watchlist by Yahoo Finance
Follow this list to discover and track stocks that have set MACD bearish crosses within the last week. A bearish crossover occurs when the MACD turns down and crosses below the signal line. Our algorithms use 12,26,9 as MACD parameters. This list is generated daily, ranked based on market cap and limited to the top 30 stocks that meet the criteria.
PayPal Holdings, Inc.
Novo Nordisk A/S
Charter Communications, Inc.
China Life Insurance Company Limited
Zoom Video Communications, Inc.
China Telecom Corporation Limited
The Clorox Company
First Republic Bank
Wheaton Precious Metals Corp.
New Oriental Education & Technology Group Inc.
China Unicom (Hong Kong) Limited
Church & Dwight Co., Inc.
Yum China Holdings, Inc.
Agnico Eagle Mines Limited
Brookfield Property Partners L.P.
Liberty Global plc
Enel Américas S.A.
Korea Electric Power Corporation
Huazhu Group Limited
ResMed and Rugby League Hall of Famer and head coach Brad Fittler are teaming up to raise Australians' awareness of the importance of healthy sleep.
(Bloomberg) -- Workday Inc. reported quarterly revenue that topped $1 billion for the first time, beating analyst estimates and continuing growth for the maker of human resources software despite the economic challenges of the pandemic. Shares rose more than 7% in extended trading.Revenue increased 23% to $1.02 billion in the fiscal first quarter, the Pleasanton, California-based company said Wednesday in a statement. On average, analysts expected $994 million, according to data compiled by Bloomberg. After some expenses, profit was 44 cents a share, compared with analyst projections of 47 cents.Workday expects subscription revenue for the fiscal year of $3.67 billion to $3.69 billion, down from as much as $3.77 billion. In the second quarter, subscription revenue will be as much as $915 million, the company said.Chief Executive Officer Aneel Bhusri has targeted a goal of $10 billion in annual revenue, from $3.6 billion the past fiscal year. The company continues to expand its human resources, accounting and planning software to offer the capabilities of established rivals Oracle Corp. and SAP SE, but delivered through the cloud. Before Workday reported results, some analysts were concerned that corporate customers aren’t interested in pursuing large software deals and complicated implementations during the Covid-19 pandemic.“The cloud is playing a critical role in today’s climate, with organizations leaning on Workday to pivot -- whether it’s helping employees learn virtually, closing books remotely, or scenario planning to determine what path to take,” Bhusri said in the statement.Workday also announced two partnerships Wednesday. One, with Microsoft Corp., will run Workday’s Adaptive Planning on the Azure cloud. Microsoft’s finance team will start using the product for its internal needs and both companies will collaborate on integrating their software products for mutual customers. The second partnership, with Salesforce.com Inc., aims to help organizations safely return to their offices in the wake of the Covid-19 pandemic.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
(Bloomberg) -- Box Inc. reported quarterly profit that easily beat Wall Street estimates, after the maker of file-sharing and collaboration software trimmed expenses. The stock rose more than 1% in extended trading.Earnings, excluding certain items, came in at 10 cents a share in the fiscal first quarter. Analysts were looking for 5 cents, on average, according to data compiled by Bloomberg. Sales rose 13% to $184 million, topping Wall Street projections.For the full fiscal year, Box forecast profit of 47 cents to 52 cents a share, compared with analysts’ estimates of 37 cents.Chief Executive Officer Aaron Levie has been under pressure to boost sales growth and profitability. He has sought to cut unnecessary expenses, and Wednesday’s results reflected that. The company said it expects an adjusted operating margin of 11% to 12% this fiscal year, up from a previous forecast of 9% to 10%. “Our Q1 results demonstrate the progress that we’ve made on driving a balance of growth and profitability, and our ability to power secure remote work for enterprises provides us a large opportunity going forward,” Levie said in a statement. Box reached an agreement in March with activist investor Starboard Value LP to appoint three new independent directors. The company unveiled a new app design and a deeper integration with Zoom Video Communications Inc. this month, in a bid to bolster the appeal of Box’s services.Now, Levie is contending with a coronavirus pandemic that has triggered a deep recession and forced millions of people to shelter at home. Box trimmed its annual sales forecast on Wednesday, suggesting weaker demand from small-business customers.Carl Bass, the former CEO of software maker Autodesk Inc. joined Box’s board, the company also announced.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
Shares of Moderna (NASDAQ: MRNA) plunged on Wednesday, following reports that several of the participants in its novel coronavirus vaccine trial suffered an adverse reaction to its experimental drug mRNA-1273. Moderna's stock surged 20% on May 18 after it shared positive results from its phase 1 study for its COVID-19 vaccine candidate mRNA-1273. Since that day, Moderna's stock has shed more than a third of its value, as analysts questioned both the timing of the stock sale and whether the preliminary data justified the price at which shares were sold.
(Bloomberg) -- SAP SE’s cloud division Chief Financial Officer Todd McElhatton will leave the German software giant to run finances at cloud-applications company Zuora Inc., the latest departure in a wave of executive exits.McElhatton will become CFO of San Mateo, California-based Zuora on June 22, a week after exiting SAP, he said in an interview. He will replace Tyler Sloat, who departed Zuora and joined Freshworks Inc. as CFO this month.McElhatton spent two years overseeing the finances of SAP’s $7 billion cloud division, which includes acquired companies such as Concur, SuccessFactors and Qualtrics. He’s one of several high-profile leaders who have departed Walldorf, Germany-based SAP within the past year. Bill McDermott, who served as chief executive officer for about a decade, stepped down from that role in October and is now CEO at ServiceNow Inc. Jennifer Morgan, one of McDermott’s two successors, departed in April after disagreements with co-CEO Christian Klein about SAP’s direction. Abdul Razack, SAP’s chief product officer, left earlier this month. With the exception of McDermott, SAP’s first American CEO, these executives have been some of the company’s highest-profile leaders based in the U.S.Zuora helps other organizations adopt and manage subscription-based business models, but it has struggled at times since its April 2018 initial public offering. The software company has posted slowing year-over-year sales growth in each quarter of the last fiscal year. The stock has declined about 19% this year and, at $11.66, is trading below its $14 IPO price.McElhatton “understands companies at our level of scale and how do we bridge from where we are to be a multibillion dollar company,” Zuora CEO Tien Tzuo said in an interview. “It’s a milestone for us in the next step of our journey.”McElhatton said Zuora is well-positioned as a company that helps businesses transform their operations.“It’s just something I couldn’t pass up and the subscription economy is even going to be a bit more relevant as we go through this post Covid-19 environment,” he said.McElhatton said it was a coincidence that several SAP leaders have left in recent months and expressed confidence in Klein and SAP’s CFO Luka Mucic.Zuora hasn’t yet reported results that reflect the effects of the coronavirus pandemic, but has pointed to how its customers are faring. In a recent analysis of clients, the company found that half saw no adverse effect on business in March and April. About 20% saw subscriptions accelerate. But notably, 17% are seeing slowing growth and 15% are contracting. Zuora is scheduled to issue results June 3.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
Shares of Arcturus Therapeutics (NASDAQ: ARCT) were plunging 32.3% as of 11:43 a.m. EDT on Wednesday. Reports surfaced yesterday that one of the participants in Moderna's phase 1 study of its COVID-19 vaccine candidate experienced a severe reaction. STAT News' Matthew Herper reported on Tuesday that Ian Haydon developed a high fever after receiving a second dose of Moderna's experimental COVID-19 vaccine.
As pharmaceutical companies rush to find a vaccine, one doctor says Trump's plan for a new vaccine by the end of the year won't happen.
Agnico (AEM) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
The Zacks Analyst Blog Highlights: Novavax, Moderna, Pfizer, Gilead and Vir Biotechnology
Is (CLX) Outperforming Other Consumer Staples Stocks This Year?
Domino's (DPZ) international sales hurt by the impact of temporary closures, partial-week openings, abbreviated store hours and limited service methods due to COVID-19 outbreak.
Consumer behavior has changed drastically since stringent social-distancing measures are in place. This opens up opportunities for some businesses.
Consumer Confidence rose for the first time since February, reflecting Americans' optimism as the economy reopens.
In the last few weeks, bio-tech companies of all sizes have made impressive strides toward a vaccine. Many dozens of approaches are being taken, most will fail. With a future potential coronavirus inoculation carrying such an overwhelmingly positive public utility, which company will win? Choosing from the companies racing to the finish line is quite difficult, and also risky.
The S&P 500 has rallied 1.2% on May 26, topping the 3,000-mark for the first time since Mar 5.
Moderna to present at upcoming investor conferences.
China Telecom Corporation Limited (HKG:728) stock is about to trade ex-dividend in 4 days time. This means that...
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Moderna, Inc. (NASDAQ: MRNA) on behalf of Moderna stockholders. Our investigation concerns whether Moderna has violated the federal securities laws and/or engaged in other unlawful business practices.
Another biotech company is hot on Moderna's trail in the race to develop a vaccine for the novel coronavirus.
Novavax announced it would begin human trials for its coronavirus vaccine, while COVID-19 engulfs Brazil.
The Dow Jones gained 3.3% last week, marking its best weekly performance since April 9.
Biotech firm Novavax has entered its coronavirus vaccine in a Phase 1 clinical trial in Australia — the first in the Southern Hemisphere.
Sentieo Data Show Google and Twitter Interest in Bitcoin Doubling So Far This Year Bitcoin and other cryptocurrencies have played a divisive role in the last few years, but recently, the interest has drawn a far wider investor base. Indeed, Paul Tudor Jones surprised Wall Street earlier this month when he revealed a significant […]